Holen Sie sich die Stockscreener-App
92.21
1.26%
-1.18
Vorhandelsmarkt:
92.56
0.35
+0.38%
Lemaitre Vascular Inc Aktie (LMAT) Neueste Nachrichten
Kennedy Capital Management LLC Has $20.11 Million Stock Position in LeMaitre Vascular, Inc. $LMAT - MarketBeat
LeMaitre Vascular Shareholders Back Directors, Pay and Auditor - TipRanks
LeMaitre Vascular, Inc. (NASDAQ:LMAT) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat
LeMaitre Vascular declares $0.25 dividend - MSN
LeMaitre Vascular (NASDAQ:LMAT) Shares Cross Above 200 Day Moving AverageTime to Sell? - MarketBeat
LMAT Q1 2026 Earnings: EPS Slightly Beats Estimates, Shares RiseEarnings Deceleration Risk - newsline.com
LeMaitre Vascular Inc. (LMAT) Q1 2026 Earnings: EPS Slightly Beats Estimates Amid Modest Stock Uptick - newsline.com
Jefferies recaps meetings with Healthcare Services companies - Investing.com
LMAT Q1 2026 Earnings: EPS Beats Estimates by 0.86%, Shares Inch HigherAnnual Report - newsline.com
LeMaitre Vascular (NASDAQ: LMAT) director gets dividend equivalent awards - Stock Titan
LeMaitre Vascular (LMAT) director receives new dividend equivalent rights grants - Stock Titan
LeMaitre (NASDAQ: LMAT) director gets dividend equivalent right awards - Stock Titan
[Form 4] LEMAITRE VASCULAR INC Insider Trading Activity - Stock Titan
LeMaitre Vascular (LMAT) director receives dividend equivalent rights awards - Stock Titan
LeMaitre Vascular (NASDAQ: LMAT) CFO receives new dividend rights awards - Stock Titan
LeMaitre Vascular (LMAT) director receives dividend equivalent right grants - Stock Titan
LeMaitre Vascular (LMAT) awards dividend equivalent rights to executive - Stock Titan
LeMaitre Vascular (NASDAQ: LMAT) CEO gifts 11,974 shares, receives dividend rights - Stock Titan
Price-Driven Insight from (LMAT) for Rule-Based Strategy - Stock Traders Daily
LeMaitre Vascular (LMAT) holders approve directors, say-on-pay and 2026 auditor - Stock Titan
LeMaitre Vascular (LMAT) Gains Ground as Stock Approaches Key ResistanceUndervalued Stocks - newsline.com
LMAT Maintained by Barrington Research -- Price Target Steady at $120 - GuruFocus
LeMaitre Vascular (NASDAQ:LMAT) Receives Outperform Rating from Barrington Research - MarketBeat
Q3 2025 LeMaitre Vascular Inc Earnings Call Transcript - GuruFocus
LMAT Q1 2026 Earnings: Modest EPS Beat Amid Steady PerformanceDiluted EPS Report - newsline.com
How The LeMaitre Vascular (LMAT) Story Is Shifting As Analysts Lift Fair Value Targets - Yahoo Finance
LMAT Q1 2026 Earnings: EPS Beats Estimates by Narrow Margin, Stock Declines SlightlyBook Value Growth - newsline.com
AlphaQuest LLC Grows Position in LeMaitre Vascular, Inc. $LMAT - MarketBeat
LeMaitre Vascular Inc. (LMAT) Holds Steady Near $98 as Traders Await CatalystTrend Continuation Trade - The Legal Advocate
LeMaitre (LMAT) is an Incredible Growth Stock: 3 Reasons Why - Yahoo Finance
(LMAT) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily
Thrivent Financial for Lutherans Grows Stock Holdings in LeMaitre Vascular, Inc. $LMAT - MarketBeat
Winners And Losers Of Q1: LeMaitre (NASDAQ:LMAT) Vs The Rest Of The Surgical Equipment & ConsumablesSpecialty Stocks - Yahoo Finance
LeMaitre Vascular to join two major healthcare investor conferences in June - Pluang
LeMaitre to Participate at Upcoming Investor Conferences in June - The Manila Times
LeMaitre schedules June talks at Jefferies and Goldman healthcare events - Stock Titan
GSA Capital Partners LLP Has $1.72 Million Position in LeMaitre Vascular, Inc. $LMAT - MarketBeat
LeMaitre Vascular (LMAT) Unchanged at $101.43 — Range-Bound Trading 2026-05-20Wedge Breakout - The Legal Advocate
LeMaitre Vascular (LMAT) Q1 2026 Results Top Views on Strong RevenueEarnings Expansion Phase - newsline.com
Three Healthcare Stocks Facing Potential Headwinds in 2026 - IndexBox
LeMaitre Vascular, Inc. (NASDAQ:LMAT) Receives Average Recommendation of "Moderate Buy" from Analysts - MarketBeat
A Quick Look at Today's Ratings for LeMaitre Vascular(LMAT.US), With a Forecast Between $105 to $124 - Moomoo
Wakefield Asset Management LLLP Buys New Position in LeMaitre Vascular, Inc. $LMAT - MarketBeat
5 Insightful Analyst Questions From LeMaitre’s Q1 Earnings Call - Yahoo Finance
LeMaitre Vascular stock (US52567J1079): Q1 beat and raised 2026 guidance - AD HOC NEWS
[SCHEDULE 13G/A] LEMAITRE VASCULAR INC Amended Passive Investment Disclosure - Stock Titan
LeMaitre Vascular Senior Vice President of Operations Trent Kamke Sells 44% Of Holding - Moomoo
(LMAT) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily
Why LeMaitre Vascular (LMAT) Is Down 10.9% After Raising 2026 Guidance And Boosting Dividends - simplywall.st
Barrington Maintains LeMaitre Vascular(LMAT.US) With Buy Rating, Raises Target Price to $120 - 富途牛牛
Down 17.2% in 4 Weeks, Here's Why LeMaitre (LMAT) Looks Ripe for a Turnaround - Yahoo Finance
LeMaitre Vascular Inc (NASDAQ:LMAT): A Quality Investing Candidate Passing All Caviar Cruise Screen Tests - ChartMill
Insider Transaction: George LeMaitre Sells $5.03M Worth Of LeMaitre Vascular Shares - Benzinga
LeMaitre Vascular stock (US52567J1079): Insiders sell amid recent price drop - AD HOC NEWS
Vanguard Group Inc. Boosts Stake in LeMaitre Vascular, Inc. $LMAT - MarketBeat
5.23%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):